EFFICACY OF VONOPRAZAN 10 MG AND 20 MG FOR PATIENTS WITH PROTON PUMP INHIBITORS (PPI)-REFRACTORY FUNCTIONAL DYSPEPSIA (FD): A DOUBLE-BLINDED, RANDOMIZED STUDY

被引:0
|
作者
Bunchorntavakul, Chalermra
Jaigla, Pantaree
Sribuathong, Nattida
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Su1634
引用
收藏
页码:S775 / S775
页数:1
相关论文
共 50 条
  • [31] EFFICACY OF TELMISARTAN 40 MG (T40) AND HYDROCHLOROTHIAZIDE 25 MG (H25) MONOTHERAPY IN HIGH SODIUM INTAKE PATIENTS WITH MILD TO MODERATE HYPERTENSION (THAT STUDY): A MULTICENTER RANDOMIZED DOUBLE-BLINDED PARALLEL CONTROLLED TRIAL
    Zhang, Puhong
    Sun, Ningling
    Wang, Hongyi
    Sun, Lei
    Zhang, Jing
    Xi, Yang
    Wu, Yangfeng
    Yan, Lijing
    JOURNAL OF HYPERTENSION, 2016, 34 : E54 - E54
  • [32] Efficacy and Safety of Subantimicrobial Dose, Modified-Release Doxycycline 40 mg Versus Doxycycline 100 mg Versus Placebo for the treatment of Inflammatory Lesions in Moderate and Severe Acne: A Randomized, Double-Blinded, Controlled Study
    Moore, Angela
    Ling, Mark
    Bucko, Alicia
    Manna, Vasant
    Rueda, Marie-Jose
    JOURNAL OF DRUGS IN DERMATOLOGY, 2015, 14 (06) : 581 - 586
  • [33] Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study
    van Zyl, JH
    Grundling, HD
    van Rensburg, CJ
    Retief, FJ
    O'Keefe, SJD
    Theron, I
    Fischer, R
    Bethke, T
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2000, 12 (02) : 197 - 202
  • [34] Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study
    Kuna, P.
    Bachert, C.
    Nowacki, Z.
    van Cauwenberge, P.
    Agache, I.
    Fouquert, L.
    Roger, A.
    Sologuren, A.
    Valiente, R.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (09): : 1338 - 1347
  • [35] Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study
    Ratner, P
    Hampel, F
    Van Bavel, J
    Howland, W
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2004, 133 (04) : 371 - 379
  • [36] A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial
    Jolicoeur, E. Marc
    Banai, Shmuel
    Henry, Timothy D.
    Schwartz, Marc
    Doucet, Serge
    White, Christopher J.
    Edelman, Elazer
    Verheye, Stefan
    TRIALS, 2013, 14
  • [37] A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial
    E Marc Jolicœur
    Shmuel Banai
    Timothy D Henry
    Marc Schwartz
    Serge Doucet
    Christopher J White
    Elazer Edelman
    Stefan Verheye
    Trials, 14
  • [38] A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia
    McEvoy, Joseph P.
    Daniel, David G.
    Carson, William H., Jr.
    McQuade, Robert D.
    Marcus, Ronald N.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2007, 41 (11) : 895 - 905
  • [39] Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized study
    Ballantyne, Christie M.
    Hoogeveen, Ron C.
    Raya, Joe L.
    Cain, Valerie A.
    Palmer, Mike K.
    Karlson, Bjorn W.
    ATHEROSCLEROSIS, 2014, 232 (01) : 86 - 93
  • [40] A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder
    Colonna, L
    Andersen, HF
    Reines, EH
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (10) : 1659 - 1668